GSK 4716 100mg | ≥99%
CSNpharm
GSK4716 is an agonist of ERRβ/γ with IC50 of 2 µM with similar potency as the protein ligand PGC-1α.
More Information Supplier PageGSK 4716
Search Results
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH 50mg | ≥98%
CSNpharm
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH can be used as a building block for solid phase glycopeptide assembly.
More Information Supplier PageFmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH 25mg | ≥98%
CSNpharm
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH can be used as a building block for solid phase glycopeptide assembly.
More Information Supplier PageFmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
PK11000 5mg | ≥99%
CSNpharm
PK11000
PK11000 10mg | ≥99%
CSNpharm
PK11000
PK11000 25mg | ≥99%
CSNpharm
PK11000
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH 5mg | ≥98%
CSNpharm
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH can be used as a building block for solid phase glycopeptide assembly.
More Information Supplier PageFmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH 1mg | ≥98%
CSNpharm
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH can be used as a building block for solid phase glycopeptide assembly.
More Information Supplier PageFmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH 100mg | ≥98%
CSNpharm
Fmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH can be used as a building block for solid phase glycopeptide assembly.
More Information Supplier PageFmoc-L-Ser(β-D-GlcNAc(Ac)3)-OH
4-HQN 5mg | ≥99%
CSNpharm
4-HQN
